| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NRG3036 |
| P698 | PubMed publication ID | 21850045 |
| P50 | author | Suzanna G.m. Frints | Q71589910 |
| P2093 | author name string | Wybo J Dondorp | |
| Christine E M de Die-Smulders | |||
| Guido M W R de Wert | |||
| Antina de Jong | |||
| P2860 | cites work | Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 |
| Increased nuchal translucency in euploid fetuses--what should we be telling the parents? | Q34020874 | ||
| Genetic testing in asymptomatic minors: Recommendations of the European Society of Human Genetics | Q34161654 | ||
| Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. | Q34168875 | ||
| Non-invasive prenatal testing: ethical issues explored | Q34328617 | ||
| Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study | Q34482155 | ||
| Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art. | Q34902566 | ||
| Evolving applications of microarray analysis in prenatal diagnosis | Q35255522 | ||
| Rapid aneuploidy detection or karyotyping? Ethical reflection | Q35304082 | ||
| Controversial ultrasound findings | Q35736144 | ||
| First trimester ultrasonography in screening and detection of fetal anomalies | Q36737302 | ||
| What's new in karyotyping? The move towards array comparative genomic hybridisation (CGH). | Q36764556 | ||
| Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases | Q36881942 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
| Time to reconsider our approach to echogenic intracardiac focus and choroid plexus cysts | Q37119113 | ||
| The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis | Q37306246 | ||
| Cell-free fetal DNA in the maternal serum and plasma: current and evolving applications | Q37406834 | ||
| Additional information from array comparative genomic hybridization technology over conventional karyotyping in prenatal diagnosis: a systematic review and meta-analysis | Q37775574 | ||
| Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age | Q37809306 | ||
| Rapid methods for targeted prenatal diagnosis of common chromosome aneuploidies | Q37840679 | ||
| Current controversies in prenatal diagnosis 3: is conventional chromosome analysis necessary in the post-array CGH era? | Q37849711 | ||
| Serious genetic disorders: can or should they be defined? | Q38436063 | ||
| Prenatal diagnosis for "minor" genetic abnormalities is ethical | Q40555870 | ||
| Individualized choice in prenatal diagnosis: the impact of karyotyping and standalone rapid aneuploidy detection on quality of life | Q46014104 | ||
| Identification of clinically significant, submicroscopic chromosome alterations and UPD in fetuses with ultrasound anomalies using genome-wide 250k SNP array analysis | Q46166434 | ||
| Prenatal testing guidelines: time for a new approach | Q46207714 | ||
| Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment | Q50128700 | ||
| Diagnostic utility of array-based comparative genomic hybridization (aCGH) in a prenatal setting. | Q51650782 | ||
| Rapid prenatal diagnosis of common chromosome aneuploidies by QF-PCR, results of 9 years of clinical experience. | Q54497048 | ||
| Rapid aneuploidy testing (knowing less) versus traditional karyotyping (knowing more) for advanced maternal age: what would be missed, who should decide? | Q54548685 | ||
| Practice guidelines for performance of the routine mid‐trimester fetal ultrasound scan | Q55953234 | ||
| Informed decision-making about the fetal anomaly scan: what knowledge is relevant? | Q56777121 | ||
| Generic Consent for Genetic Screening | Q56894329 | ||
| Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus | Q56937251 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy | Q80138010 | ||
| Prenatal cytogenetic diagnosis: gone FISHing, BAC soon! | Q80848893 | ||
| Current controversies in prenatal diagnosis 3: For prenatal diagnosis, should we offer less or more than metaphase karyotyping? | Q82622985 | ||
| Rapid aneuploidy screening with fluorescence in-situ hybridisation: is it a sufficiently robust stand-alone test for prenatal diagnosis? | Q82767546 | ||
| ACOG Committee Opinion No. 446: array comparative genomic hybridization in prenatal diagnosis | Q82958875 | ||
| Prenatal testing for Down syndrome: comparison of screening practices in the UK and USA | Q84836506 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 657-663 | |
| P577 | publication date | 2011-08-18 | |
| P1433 | published in | Nature Reviews Genetics | Q1071824 |
| P1476 | title | Advances in prenatal screening: the ethical dimension | |
| P478 | volume | 12 |
| Q40223085 | 'Hope for safe prenatal gene tests'. A content analysis of how the UK press media are reporting advances in non-invasive prenatal testing |
| Q38780309 | A Framework for Unrestricted Prenatal Whole-Genome Sequencing: Respecting and Enhancing the Autonomy of Prospective Parents |
| Q56772308 | A new era in prenatal testing: are we prepared? |
| Q46215286 | A prospective study of the clinical utility of prenatal chromosomal microarray analysis in fetuses with ultrasound abnormalities and an exploration of a framework for reporting unclassified variants and risk factors. |
| Q34862292 | Acceptability of prenatal testing and termination of pregnancy in Pakistan |
| Q48280857 | Amniocentesis is still the best option for advanced genomic testing in case of fetal malformations |
| Q37615461 | An exploratory study to develop a practical ethical framework for reproductive health research |
| Q56774558 | Arrays in postnatal and prenatal diagnosis: An exploration of the ethics of consent |
| Q43902229 | Attitudes among Danes toward prenatal testing and termination of pregnancy |
| Q34508235 | Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening |
| Q35447245 | Attitudes towards non-invasive prenatal testing for aneuploidy among US adults of reproductive age. |
| Q58087340 | Benefits, challenges and ethical principles associated with implementing noninvasive prenatal testing: a Delphi study |
| Q33754305 | Best ethical practices for clinicians and laboratories in the provision of noninvasive prenatal testing |
| Q36321452 | Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US context |
| Q47751664 | Chromosome Screening Using Noninvasive Prenatal Testing Beyond Trisomy-21: What to Screen for and Why It Matters. |
| Q39200097 | Client views and attitudes to non-invasive prenatal diagnosis for sickle cell disease, thalassaemia and cystic fibrosis |
| Q37504505 | Commercial landscape of noninvasive prenatal testing in the United States |
| Q28286723 | Dynamics and ethics of comprehensive preimplantation genetic testing: a review of the challenges |
| Q58106704 | Ethical Concerns in the Implementation of DNA Sequencing-Based Noninvasive Prenatal Testing for Fetal Aneuploidy Among Obstetric Professionals in Hong Kong |
| Q37397787 | Ethical issues in preconception genetic carrier screening |
| Q35211959 | Ethical, legal, social, and policy implications of behavioral genetics. |
| Q53079759 | Exploring the Issues Surrounding Clinical Exome Sequencing in the Prenatal Setting. |
| Q38119478 | Factors affecting the clinical use of non-invasive prenatal testing: a mixed methods systematic review |
| Q53171434 | Generating a taxonomy for genetic conditions relevant to reproductive planning. |
| Q38547871 | Genomic futures of prenatal screening: ethical reflection |
| Q34244450 | Genomics and perinatal care |
| Q58106669 | Hoping Someday Never Comes: Deferring Ethical Thinking About Noninvasive Prenatal Testing |
| Q35800201 | Is routine karyotyping required in prenatal samples with a molecular or metabolic referral? |
| Q57809529 | Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals |
| Q58663048 | Microarrays as a diagnostic tool in prenatal screening strategies: ethical reflection |
| Q34345162 | Molecular genetic testing and the future of clinical genomics |
| Q50596773 | NIPT-based screening for Down syndrome and beyond: what do pregnant women think? |
| Q39213958 | NIPT: current utilization and implications for the future of prenatal genetic counseling. |
| Q36279569 | Newborn screening and the era of medical genomics |
| Q36079264 | Non-invasive prenatal diagnosis by massively parallel sequencing of maternal plasma DNA. |
| Q38088416 | Non-invasive prenatal diagnostics using next generation sequencing: technical, legal and social challenges |
| Q36184534 | Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening |
| Q26999426 | Non-invasive prenatal testing: a review of international implementation and challenges |
| Q22242878 | Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012 |
| Q35845489 | Old Questions, New Paradigms: Ethical, Legal, and Social Complications of Noninvasive Prenatal Testing |
| Q38659564 | Opening Pandora's box?: ethical issues in prenatal whole genome and exome sequencing |
| Q56769559 | Physician liability and non-invasive prenatal testing |
| Q57947198 | Pregnant couples at increased risk for common aneuploidies choose maximal information from invasive genetic testing |
| Q92995871 | Prenatal genetic testing for cystic fibrosis: a systematic review of clinical effectiveness and an ethics review |
| Q35045004 | Prenatal screening, reproductive choice, and public health. |
| Q58106679 | Printing Unrealistic Expectations: A Closer Look at Newspaper Representations of Noninvasive Prenatal Testing |
| Q33843847 | Qualifying choice: ethical reflection on the scope of prenatal screening. |
| Q38344058 | Rare inherited disorders with renal involvement-approach to the patient |
| Q39921334 | Should I Perform Genetic Testing? A Qualitative Look into the Decision Making Considerations of Religious Israeli Undergraduate Students |
| Q50941499 | Support Desired by Women Following Termination of Pregnancy for a Fetal Anomaly. |
| Q41640999 | The effect of a decision aid on informed decision-making in the era of non-invasive prenatal testing: a randomised controlled trial |
| Q38016971 | The evolution of prenatal screening and diagnosis and its impact on an unselected population over an 18-year period |
| Q30317953 | The perspective from EASAC and FEAM on direct-to-consumer genetic testing for health-related purposes |
| Q84928397 | To know or not to know the genomic sequence of a fetus |
| Q38048368 | Universal screening for inherited metabolic diseases in the neonate (and the fetus). |
| Q44558105 | Variables influencing pregnancy termination following prenatal diagnosis of fetal chromosome abnormalities |
| Q56772393 | Views and preferences for the implementation of non-invasive prenatal diagnosis for single gene disorders from health professionals in the United Kingdom |
| Q37333449 | Will the introduction of non-invasive prenatal testing for Down's syndrome undermine informed choice? |
| Q57839583 | Women’s and health professionals’ preferences for prenatal tests for Down syndrome: a discrete choice experiment to contrast noninvasive prenatal diagnosis with current invasive tests |
| Q36561826 | Work environment facilitators to the availability of complementary and alternative therapies in perinatal hospices. |
Search more.